Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

 24.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 45.85
  • 52 Week Low: 17.70
  • Currency: UK Pounds
  • Shares Issued: 741.51m
  • Volume: 9,300,340
  • Market Cap: £179.44m

Benchmark posts strong results as aquaculture markets recover

By Josh White

Date: Monday 29 Nov 2021

LONDON (ShareCast) - (Sharecast News) - Aquaculture biotechnology company Benchmark reported "strong" full-year results on Monday, with revenue from continuing operations increasing 18% to £125.2m, or 24% at constant exchange rates.
The AIM-traded firm said its adjusted EBITDA was ahead 34% for the year ended 30 September at £19.4m, or 43% at constant currency, which it put down to its "transformation" and "focussed" strategy.

It recorded a strong trading performance, with strategic progress across its three business areas.

In advanced nutrition, Benchmark returned to growth thanks to a renewed commercial focus and a recovery in shrimp markets, with revenues improving by 19%, or 27% at constant exchange rates.

Genetics saw continued revenue growth of 13%, or 15% at constant currency, with "significant" investment made, and progress reported towards its growth opportunities.

In health, Benchmark launched a new sea lice solution 'Ectosan Vet', as well as 'CleanTreat' in Norway and achieved first sales, with the treatments said to be delivering "excellent" efficacy.

Benchmark said it made "disciplined" investment in growth areas during the year, with capital expenditure totalling £23m.

Cash and cash equivalents totalled £39.5m at year end, with available liquidity standing at £50.6m.

"2021 was a very successful year for Benchmark with much accomplished financially, operationally and strategically," said chief executive officer Trond Williksen.

"The group delivered a strong financial performance across its three business areas reflecting our new commercial focus and supported by improving conditions, particularly in our important shrimp market which had been hardest hit by the pandemic."

Williksen said there was "good momentum" in the business, helped by positive conditions in its markets, contributing to a "good start" to the new financial year across the business areas, consistent with Benchmark's outlook for the year as a whole.

"The aquaculture industry increasingly recognises the importance of an integrated approach to sustainability across the value chain which Benchmark is uniquely positioned to deliver through our range of solutions, underpinning our focus on delivering profitable growth."

At 1015 GMT, shares in Benchmark Holdings were up 2.24% at 63.9p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BMK Market Data

Currency UK Pounds
Share Price 24.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 45.85
52 Week Low 17.70
Volume 9,300,340
Shares Issued 741.51m
Market Cap £179.44m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.71% above the market average64.71% above the market average64.71% above the market average64.71% above the market average64.71% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Price Trend
75.53% below the market average75.53% below the market average75.53% below the market average75.53% below the market average75.53% below the market average
48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average
Income Not Available
Growth
57.19% below the market average57.19% below the market average57.19% below the market average57.19% below the market average57.19% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
16:35 19 @ 24.20p
16:35 19 @ 24.20p
15:13 408 @ 23.80p
13:39 911 @ 24.00p
13:39 459 @ 24.00p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen
Chair Tripp Lane

Top of Page